Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 117 participants.
Also called NCT07583147
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose basic science
- Phase
- Phase 2
- Enrolled
- 117 participants
- Registry
-
NCT07583147 -
2025-521923-58-00
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- France
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07583147. Allocation not applicable; no masking; primary purpose basic science. Start 2026-06 (anticipated); primary completion 2029-09 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Role of Neuroinflammation and Blood-Brain Barrier Breakdown in Intracerebral Hemorrhage.
- Acronym
- INFINITE
- Condition
- Intracerebral Hemorrhage
- Intervention (Drug)
- TEP with 18F-DPA-714 injection
- Lead sponsor
- University Hospital, Toulouse
Record details
- Record id
cardio:ct-nct07583147- Content hash
e64307921b5cef18d0c8c2602be357351458ed7890100ce5a901365660303b99